Scientists uncover cerebrospinal fluid markers for Alzheimer's detection and treatment
Researchers map the unique genetic regulation of proteins in human cerebrospinal fluid, identifying potential targets for Alzheimer’s treatments.
Study reveals role of 3D environments in influencing bacterial survival and growth
For over 300 years, scientists have studied bacteria primarily using liquid cultures or flat 2D plates in laboratory settings
New biomarker could help predict Parkinson’s disease progression
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
Study reveals how 3D environments affect bacterial growth and survival
NCBS study reveals how 3D environments impact bacterial growth, highlighting the importance of shape in survival strategies.
Study reveals how 3D environments affect bacterial growth and survival
NCBS study reveals how 3D environments impact bacterial growth, highlighting the importance of shape in survival strategies.
Synthetic cells successfully emulate natural cellular communication
A research team from the University of Basel has succeeded in synthesizing simple, environmentally sensitive cells complete with artificial organelles. For the first time, the researchers have also been ...
TYK2 inhibition may offer new strategy to reduce tau toxicity in Alzheimer's
Researchers at Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children's Hospital and collaborating institutions discovered that the enzyme TYK2 transforms the normal protein tau into one that accumulates in the brain and contributes to the development of Alzheimer's disease in animal models.
Using CRISPR to decipher whether gene variants lead to cancer
In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the genetic material of living organisms. One application is in cell therapy: A patient's ...
Nomic® and Parker Institute for Cancer Immunotherapy (PICI) launch large-scale protein profiling to investigate immunotherapy responses in RADIOHEAD study
Nomic Bio and PICI collaborate to quantify protein biomarkers in cancer immunotherapy, enhancing understanding of patient responses and treatment resistance.
Patient-derived organoids: Transforming cancer research and personalized medicine
Patient-derived organoids (PDOs) are revolutionizing cancer research, enhancing drug testing and personalized treatment through advanced 3D modeling techniques.
MethylGPT unlocks DNA secrets for age and disease prediction
Researchers developed MethylGPT, a powerful transformer-based model that identifies DNA methylation patterns, enabling advanced age and disease prediction with clinical potential.
Revolutionary AI predicts aging and disease from DNA patterns
Researchers developed CpGPT, a novel foundation model for DNA methylation analysis that captures sequence, positional, and epigenetic context to predict aging and disease risks. This model offers breakthroughs in imputing missing data and improving mortality and morbidity predictions.
'Moonlighting' enzymes can lead to new cancer therapies
Researchers reveal that metabolic enzymes known for their roles in energy production and nucleotide synthesis are taking on unexpected 'second jobs' within the nucleus, orchestrating critical functions like cell division and DNA repair. The discovery not only challenges longstanding biological paradigms in cellular biology but also opens new avenues for cancer therapies, particularly against aggressive tumours like triple-negative breast cancer (TNBC).
New AI model improves prediction power for genomics related to disease
To understand the workings of DNA in relation to disease, scientists at Los Alamos National Laboratory have developed the first multimodal deep learning model of its kind, EPBDxDNABERT-2, capable of ascertaining ...
New CRISPR system for gene silencing doesn't rely on cutting DNA
Scientists from Vilnius University's (VU) Life Sciences Center (LSC) have discovered a unique way for cells to silence specific genes without cutting DNA. This research, led by Prof. Patrick Pausch and ...
New microscope shows live imaging of nanoscale biological process for the first time
In Nijmegen, Netherlands, researchers have installed the world's first microscope capable of live imaging of biological processes in such detail that moving protein complexes are visible. This new microscopic ...
Researchers identify a potential biomarker of Parkinson's disease progression
Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of the pathology would have a significant increase in the levels of a molecule called ecto-GPR37 in the cerebrospinal fluid.
Super microscope shows nanoscale biological process for the first time
A new microscope is capable of live imaging of biological processes in such detail that moving protein complexes are visible.
Synthetic cells emulate natural cellular communication
A research team has succeeded in synthesizing simple, environmentally sensitive cells complete with artificial organelles. For the first time, the researchers have also been able to emulate natural cell-cell communication using these proto-cells -- based on the model of photoreceptors in the eye. This opens up new possibilities for basic research and applications in medicine.
Unexpected differences in genetically identical bacteria provide a new perspective on aging at the cellular level
Surprising findings on bacterial aging have emerged from a study carried out by a team of researchers led by the biologist Dr. Ulrich Steiner at Freie Universität Berlin. In a new paper published in ...
Using CRISPR to decipher whether gene variants lead to cancer
Researchers have combined two gene editing methods. This enables them to quickly investigate the significance of many genetic mutations involved in the development and treatment of cancer.
last updated on 14 Nov 16:23